Last deal

$30M

Amount

Venture - Series Unknown

Stage

14.10.2010

Date

2

all rounds

$30M

Total amount

date founded

Financing round

General

About Company
Prolong Pharmaceuticals develops and markets biopharmaceutical products for various diseases.

Industry

Sector :

Subsector :

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Prolong Pharmaceuticals is a biopharmaceutical company that focuses on developing and marketing products to treat a range of diseases. Their offerings include PEG-uricase for hyperuricemia, PEG-arginase for melanoma and hepatocellular carcinoma, PEG-protein for hypovolemic shock, PEG-peptide antibiotic for staphylococcus infections, PEG-streptokinase for myocardial infarcts, anti-cancer agents, and Erythropoietin for anemia. In addition to product development, the company also provides custom manufacturing services and licenses its products to other pharmaceutical companies. With a foundation in 2002 and headquartered in New Jersey, Prolong Pharmaceuticals plays a crucial role in improving the quality of life for patients with various diseases by addressing their specific medical needs and advancing the fields of hematology and oncology.
Similar Companies
999
Anthera Pharmaceuticals

Anthera Pharmaceuticals

Anthera Pharmaceuticals develops and sells treatments for inflammation-related diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Hayward, CA, USA

total rounds

5

total raised

$101.5M
ViroPharma

ViroPharma

ViroPharma is a biopharmaceutical company that develops and commercializes products for serious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Exton, PA 19341, USA

total rounds

1
Omni Bio Pharmaceutical

Omni Bio Pharmaceutical

Omni Bio Pharmaceutical, Inc. is a pharmaceutical company.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Greenwood Village, CO, USA

total rounds

5

total raised

$10.09M
Lewis and Clark Pharmaceuticals

Lewis and Clark Pharmaceuticals

Lewis and Clark Pharmaceuticals develops potent treatments for cancer and inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Charlottesville, VA, USA

total rounds

2

total raised

$475K

Financials

Funding Rounds
2
2

Number of Funding Rounds

$30M

Money Raised

Their latest funding was raised on 14.10.2010. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
14.10.2010
$30M
01.01.2009
1
Co-Investors
Investors
1
0

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
No
Seed
Tarsadia

Tarsadia

Tarsadia is a California-based family office investment firm that invests in category-defining companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Newport Beach, CA, USA

count Of Investments

17

count Of Exists

1

People

Founders
1
Abraham Abuchowski
Abraham Abuchowski

Abraham Abuchowski

Dr. Abuchowski was the originator of PEGylation technology, now the most widely used protein drug delivery system in the world. He was the founder and past Chairman and CEO of Enzon, Inc., the biopharmaceutical company that commercialized PEGylation technology. During his 13 years at Enzon, Dr. Abuchowski successfully commercialized PEGylation by gaining FDA approval for three protein-based drugs. Dr. Abuchowski was instrumental in helping Enzon mature from a developmental stage company to a fully integrated publicly traded biopharmaceutical company. Dr. Abuchowski holds a B.S. and Ph.D. in Biochemistry from Rutgers University. He is an internationally recognized authority on drug delivery and has published numerous scientific papers and several book chapters on therapeutic products. In 1994, Dr. Abuchowski founded the Biotechnology Council of New Jersey and served as its first Chairman.

current job

Prolong Pharmaceuticals
Prolong Pharmaceuticals

organization founded

1

Abraham Abuchowski

Employee Profiles
1
Abraham Abuchowski

Abraham Abuchowski

Founder and CEO

Activity

Recent News
1